Clinical Trial Detail

NCT ID NCT00223665
Title Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

prostate adenocarcinoma

Therapies

Leuprolide

Flutamide

Age Groups: adult

No variant requirements are available.